The National Institute for Health and Care Excellence (NICE) recently issued guidelines for a new drug called vedolizumab as a treatment option for patients with ulcerative colitis (UC) or Crohn’s disease (CD).

This is a significant development because it is the first new type of biological treatment for UC and CD in a decade. Vedolizumab targets a specific protein involved in chronic inflammation that is found only in the intestine. As a result, treatment with vedolizumab may reduce inflammation of the intestine with less side effects and risks that other biological treatments.

Vedolizumab is now available on the NHS. If you would like to find out more about this treatment option, we recommend speaking with your doctor.

Although traditionally considered fringe therapy, and perhaps an unattractive last resort to treat Clostridium difficile (a bacterial infection that can affect the digestive system), faecal microbiota transplant (FMT) has experienced a surge in interest and popularity, both in clinical practice and research, over the past two to three years. FMT, also known as faecal transplant, is a process whereby healthy stool (i.e. faecal matter, which harbors a positive community of microorganisms or bacteria) is transplanted from a healthy donor to a patient. There are various methods that this can be achieved: via endoscopy, nasogastric tubing, or the ingestion of pills. The idea behind FMT is that ‘unhealthy’ or unbalanced communities of bacteria, which are present in conditions ranging from SIBO (small intestine bacterial overgrowth), to IBS and UC, could be rectified and ‘flushed out’ by introducing healthy colonies of bacteria. Although FMT has not yet been approved as a treatment option by the NHS, it has been approved for research trials. In a recent study (Gastroenterology 2015;149:102-109), FMT was seen to induce remission in a significantly greater percentage of patients with active UC than placebo, with no difference in adverse events. This appears to demonstrate the potential benefits of this treatment option. Whilst the general consensus on FMT currently is not clear, and there are several conflicting studies, it would not be surprising to see this low-cost and relatively controversial treatment option continue to increase in popularity in the coming years.

At West Kent Gastroenterology, we work hard to provide our patients with top-class care. You will enjoy friendly, fast and modern treatment by a highly experienced gastroenterologist. We carefully review patient satisfaction and feedback, and at West Kent Gastroenterology we are continuously making improvements to our services, ensuring the highest level of care possible.

Clinic Locations

Nuffield Hospital
Kingswood Road, Tunbridge Wells, TN2 4UL

Spire Hospital
Fordcombe Road, Tunbridge Wells, Kent, TN3 0RD

Sevenoaks Medical Centre
London Road, Sevenoaks, Kent, TN13 2JD


@dradamharris - 2 months

Very pleased to be working as consultant physician at looking after patients from to c…

@dradamharris - 2 months

Analysis of food questionnaires in over 520,000 people showed that regular consumption of fish was associated with…

© 2020 West Kent Gastroenterology Ltd.

Designed and Developed By